Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LDRX | 33.21 | N/A | N/A |
| SGI Enhanced Market Leaders ETF | |||
| ESMV | 28.53 | N/A | N/A |
| iShares ESG Optd MSCI USA Min Vol FacETF | |||
| FEP | 51.79 | -0.06 | -0.12% |
| First Trust Europe AlphaDEX® ETF | |||
| VEGI | 39.12 | -0.23 | -0.58% |
| iShares MSCI Agriculture Producers ETF | |||
| PPLT | 143.60 | -3.87 | -2.62% |
| abrdn Physical Platinum Shares ETF | |||
A.I.dvisor indicates that over the last year, ROQAF has been loosely correlated with GNTA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ROQAF jumps, then GNTA could also see price increases.
| Ticker / NAME | Correlation To ROQAF | 1D Price Change % | ||
|---|---|---|---|---|
| ROQAF | 100% | N/A | ||
| GNTA - ROQAF | 36% Loosely correlated | +0.91% | ||
| CRBP - ROQAF | 22% Poorly correlated | +7.39% | ||
| SVRA - ROQAF | 21% Poorly correlated | -4.85% | ||
| SKYE - ROQAF | 21% Poorly correlated | +4.11% | ||
| SNTI - ROQAF | 6% Poorly correlated | +3.28% | ||
More | ||||